Our technology gives failed drug molecules a second chance.

Month: December 2018

10.12.2018 Nanoform continues rapid expansion with construction of GMP manufacturing plant

PRESS RELEASE 10 December 2018 Nanoform continues rapid expansion with construction of GMP manufacturing plant Helsinki, Finland – Nanoform, an innovative drug enabling nanotechnology company, has announced the construction of a GMP manufacturing plant to provide API ‘solution to particle’ nanonization for clinical trials. A nine-year contract has been signed to build the 600m2 facility …

10.12.2018 Nanoform continues rapid expansion with construction of GMP manufacturing plantRead More »